Rockwell Medical (RMTI) Share-based Compensation (2010 - 2026)
Rockwell Medical (RMTI) reported Share-based Compensation of $479000.0 for Q1 2026, up 7.64% on a YoY basis from $445000.0 in Q1 2025, and up 4.81% quarter-over-quarter from $457000.0 in Q4 2025.
Rockwell Medical (RMTI) Share-based Compensation (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Share-based Compensation for 17 years, with the latest figure at $479000.0 in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 7.64% year-over-year to $479000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 24.5% YoY), and the FY2025 full-year result was $1.8 million, up 40.56% from the prior year.
- Share-based Compensation for Q1 2026 stood at $479000.0, up from $457000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $532000.0 in Q3 2025, with the low at -$179000.0 in Q1 2022.
- Historically, Share-based Compensation has averaged $284352.9 across 5 years, with a median of $309000.0 in 2023.
- Annual changes were most pronounced in 2022 — Share-based Compensation sank 77.6% — and 2023, when it soared 218.56%.
- Rockwell Medical's Share-based Compensation stood at $220000.0 in 2022, then fell by 0.91% to $218000.0 in 2023, then jumped by 75.23% to $382000.0 in 2024, then increased by 19.63% to $457000.0 in 2025, then rose by 4.81% to $479000.0 in 2026.
- The last three Share-based Compensation figures came in at $479000.0 (Q1 2026), $457000.0 (Q4 2025), and $532000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | 479,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 479,000.00 |
| Mar 31, 2026 | 479,000.00 |
| Dec 31, 2025 | 457,000.00 |
| Dec 31, 2025 | 457,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 382,000.00 |
| Mar 31, 2025 | 445,000.00 |
| Mar 31, 2025 | 445,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 321,000.00 |
| Sep 30, 2024 | 321,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Mar 31, 2024 | 251,000.00 |
| Mar 31, 2024 | 251,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2023 | 218,000.00 |